Cell adhesion molecules and immunotherapy in advanced non-small cell lung cancer: Current process and potential application
Advanced non-small cell lung cancer (NSCLC) is a severe disease and still has high mortality rate after conventional treatment (e.g., surgical resection, chemotherapy, radiotherapy and targeted therapy). In NSCLC patients, cancer cells can induce immunosuppression, growth and metastasis by modulatin...
Main Authors: | Hongjian Yang, Yuxi Miao, Zhaojin Yu, Minjie Wei, Xue Jiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1107631/full |
Similar Items
-
Elimination of cDC1 cells by regulatory T cells jeopardizes cancer immunotherapy
by: Peng Liu, et al.
Published: (2024-12-01) -
Adhesion molecules /
by: Preedy, Victor R.
Published: (c201) -
The Evolution of Cancer Immunotherapy
by: Meshaal Khan, et al.
Published: (2021-06-01) -
Emerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer
by: Emily Wolf, et al.
Published: (2025-01-01) -
Immunological and translational aspects of NK cell-based anti-tumor immunotherapies
by: Maxim Shevtsov, et al.
Published: (2016-11-01)